Is neuroblastoma a cancer?

Written by Chen Yu Fei
Neurosurgery
Updated on September 12, 2024
00:00
00:00

Neuroblastoma is a highly malignant tumor, one of the most malignant among neuroepithelial tumors, and thus can be considered as cancer from this perspective. Typically, its tumor biology growth pattern is that of a malignant tumor, often growing rapidly. In the early stages of the disease, it tends to adhere closely to surrounding tissues, making it difficult for surgery to be completely successful. In addition, during treatment, it can be observed that the tumor cells are highly invasive to surrounding tissues. This often leads to significant brain edema, resulting in compression of important surrounding blood vessels and nerves, causing functional damage. The tumor can also spread through the bloodstream, making it difficult to completely remove surgically, or to miss the optimal time for surgical treatment, resulting in a poor prognosis.

Other Voices

doctor image
home-news-image
Written by Chen Yu Fei
Neurosurgery
40sec home-news-image

Precursors to neuroblastoma recurrence

For neuroblastoma, if recurrence occurs, the patient may show symptoms like recurrent headaches, dizziness, nausea, and vomiting. Additionally, if the optic nerve is involved, there may be a decrease in vision and visual field defects. Even the possibility exists that the tumor could recur, increase in size, and compress surrounding important blood vessels and nerves, leading to an increase in intracranial pressure, which manifests as worsening of the original symptoms of headaches and dizziness. Once such symptoms occur, it generally suggests a high likelihood of neuroblastoma recurrence. If it causes symptoms such as hemiplegia and aphasia, it can generally be confirmed.

doctor image
home-news-image
Written by Chen Yu Fei
Neurosurgery
41sec home-news-image

Can neuroblastoma be treated?

Neuroblastoma is the most common tumor in childhood, and it is also the most common in infants and toddlers. Typically, neuroblastoma is a type of neuroendocrine tumor, clinically found often in the adrenal glands or in nervous tissues such as the neck, chest, and abdomen. Currently, neuroblastoma can be effectively classified according to its level of risk into low-risk, intermediate-risk, or high-risk groups. For patients in the low-risk group, surgical treatment can achieve satisfactory results; for patients in the intermediate-risk or high-risk groups, treatment often involves a combination of methods, yet still may not achieve satisfactory results.

doctor image
home-news-image
Written by Chen Yu Fei
Neurosurgery
44sec home-news-image

Can neuroblastoma be cured?

Neuroblastoma is a malignant tumor that often grows rapidly. In the early stages of the disease, it can easily invade surrounding tissues and nerves, making it very difficult to completely remove the tumor through surgery. In most cases, even after surgical treatment, there is a high tendency for recurrence in children, making it difficult to achieve a clinical cure. For most patients with neuroblastoma, early post-surgical treatment involving high doses of radiotherapy and chemotherapy can effectively reduce the likelihood of tumor recurrence and appropriately prolong the patient’s lifespan. This helps in extending the lifespan and improving the quality of life to some extent, but generally, the final prognosis remains poor.

doctor image
home-news-image
Written by Chen Yu Fei
Neurosurgery
48sec home-news-image

Neuroblastoma examination items

For neuroblastoma, the examination items mainly include the patient's vital signs and physical examination, including detailed examinations to observe if there are any obvious pathological signs. Additionally, it is necessary to inquire about the patient’s medical history, especially past medical history and family history. Main examination items include laboratory tests, routine blood and urine tests, biochemistry, and tumor-related tests. Furthermore, examinations also involve using a cranial CT scan, MRI of the head, and if necessary, an enhanced MRI scan of the head, to further determine the presence of neuroblastoma, as well as its location, quantity, and the relationship between the surrounding tissues, blood vessels, and nerves.

doctor image
home-news-image
Written by Chen Yu Fei
Neurosurgery
46sec home-news-image

Is neuroblastoma serious?

Neuroblastoma is relatively serious and is classified as a highly malignant tumor, one of the epithelial cell tumors. The disease often leads to severe intracranial pressure increases, manifesting as intense headaches, dizziness, nausea, vomiting, and even possible optic disc edema, vision loss, and visual field defects. The occurrence of neuroblastoma often indicates a poor prognosis for patients, with a short disease duration and reduced survival time. The five-year survival rate is decreased. Treatment primarily involves surgical intervention to completely remove the neuroblastoma, followed by postoperative radiotherapy, chemotherapy, and other related treatments.